| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |